Identifying Medications Underlying Communication Atypicalities in Psychotic and Affective Disorders: A Pharmacovigilance Study Within the FDA Adverse Event Reporting System.

Purpose: Communication atypicalities are considered promising markers of a broad range of clinical conditions. However, little is known about the mechanisms and confounders underlying them. Medications might have a crucial, relatively unknown role both as potential confounders and offering an insigh...

Descripción completa

Detalles Bibliográficos
Publicado en:	Journal of Speech, Language & Hearing Research Vol. 66; no. 9; pp. 3242 - 3260
Autores principales:	Fusaroli, Michele, Simonsen, Arndis, Borrie, Stephanie A., Low, Daniel M., Parola, Alberto, Raschi, Emanuel, Poluzzi, Elisabetta, Fusaroli, Riccardo
Formato:	Artículo
Publicado:	American Speech-Language-Hearing Association Sep2023
Materias:	United States. Food & Drug Administration Psychoses Communicative disorders Affective disorders Drugs Drug side effects Statistics Parasympathomimetic agents Confidence intervals Pharmacology Data analysis Vascular endothelial growth factors Odds ratio Comorbidity Antipsychotic agents
Acceso en línea:	Ver este registro en EBSCOhost